Botfet / Company detail
TNDM
rejectedTandem Diabetes Care, Inc.
biotech
Moat scoreNot available: not scored quality failout of 100
Rejectionquality_fail
The numbers
Financial metrics
Roic-11.9%
Gross Margin52.3%
Revenue Cagr9.6%
Fcf Conversion14.5%
Fcf Yield-2.4%
Interest Coverage-22.1x
Market Cap B$1.2B
PeNot available: not applicable loss making
Quality PassFail
Founder LedNo
Thesis AlignedYes
Moat QuantNot available: not scored quality fail
Why it may endure
Moat breakdown
Market Share StabilityNot available: not scored quality fail
Network EffectsNot available: not scored quality fail
Pricing PowerNot available: not scored quality fail
Regulatory MoatNot available: not scored quality fail
Switching CostsNot available: not scored quality fail
ConvictionNot available: not scored quality fail
LeadershipNot available: not scored quality fail
VisionNot available: not scored quality fail